JAZZ Jazz Pharmaceuticals Plc

$224.57 -1.07%

Healthcare · Pharmaceutical Preparations

Jazz Pharmaceuticals Plc (JAZZ) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $14.1 billion. Shares last traded at $224.57, 7.7% below their 52-week high. Over the past year the stock is up 109.9%. Net profit margin is -8.3%, below the peer median of -0.1%. Revenue grew 4.9% year over year.

Market Cap

$14.1B

Shares Out

62.7M

EPS (TTM)

$-19.55

P/E Ratio

—

P/S Ratio

3.30

P/B Ratio

3.11

Dividend / Share

—

Dividend Yield

—

52-Week High

$243.25

52-Week Low

$105.08

Volume

50,947

Avg Vol (3m)

51,669.27

Performance

-4.91%

-5.41%

+23.51%

+32.29%

YTD

+29.75%

+109.93%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

45.72

SMA (50)

$220.24

SMA (200)

$175.04

Price vs SMA50

+1.97%

Price vs SMA200

+28.30%

ATR (14)

$6.66

Financials

Revenue

$4.3B

Net Income

$-356M

Gross Margin

—

Operating Margin

-10.1%

Net Margin

-8.3%

Return on Equity

-7.9%

Return on Assets

-3.0%

Current Ratio

2.04

Debt / Equity

1.18

Revenue Growth (YoY)

+4.9%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$4.43	2026-05-05
FY 2025	$-5.84	2026-02-24
Q3 2025	$-9.18	2025-11-05
Q2 2025	$-13.28	2025-08-06
Q1 2026	$-1.52	2026-05-05
FY 2025	$8.65	2026-02-24

Full earnings history →

Pharmaceutical Preparations peers

JAZZ vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

3.30 / 3.54 med

-7% discount

Net margin vs peers

-8.3% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.